Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma

Affiliations

¹ 1 Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
² 2 Fred Hutchinson Cancer Research Center, Seattle, WA.

Comment

Bronwen E Shaw et al. J Clin Oncol. 2019.

. 2019 Jul 1;37(19):1598-1600.

doi: 10.1200/JCO.19.00865. Epub 2019 May 14.

¹ 1 Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
² 2 Fred Hutchinson Cancer Research Center, Seattle, WA.

No abstract available

Comment on

Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Ahmedzai SH, Snowden JA, Ashcroft AJ, Cairns DA, Williams C, Hockaday A, Cavenagh JD, Ademokun D, Tholouli E, Allotey D, Dhanapal V, Jenner M, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Parrish C, Brown JM, Morris TCM, Cook G; National Cancer Research Institute Haemato-Oncology Clinical Studies Group. Ahmedzai SH, et al. J Clin Oncol. 2019 Jul 1;37(19):1617-1628. doi: 10.1200/JCO.18.01006. Epub 2019 Apr 10. J Clin Oncol. 2019. PMID: 30969846 Free PMC article. Clinical Trial.

1. Calvert M, Blazeby J, Altman DG, et al. Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA. 2013;309:814–822. - PubMed
1. Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension. JAMA. 2018;319:483–494. - PubMed
1. Ahmedzai SH, Snowden JA, Ashcroft AJ, et al. Patient-reported outcome results from the open-label, randomized phase III Myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. J Clin Oncol. 2019;37:1617–1628. - PMC - PubMed
1. Nielsen LK, Abildgaard N, Jarden M, et al. Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma. Br J Haematol. 2019;185:11–24. - PubMed
1. Sparano F, Cavo M, Niscola P, et al. Patient-reported outcomes in relapsed/refractory multiple myeloma: A systematic review. Support Care Cancer. 2018;26:2075–2090. - PubMed